<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0011713'>Left bundle branch block</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">LBBB</z:e>) is generally associated with a poorer prognosis in comparison to <z:mpath ids='MPATH_458'>normal</z:mpath> intraventricular conduction, but also in comparison to <z:hpo ids='HP_0011712'>right bundle branch block</z:hpo> which is generally considered to be benign in the absence of an underlying <z:e sem="disease" ids="C0018799" disease_type="Disease or Syndrome" abbrv="">cardiac disorder</z:e> like <z:hpo ids='HP_0002564'>congenital heart disease</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain><z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">LBBB</z:e> may be the first manifestation of a more diffuse <z:e sem="disease" ids="C0878544" disease_type="Disease or Syndrome" abbrv="">myocardial disease</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>The typical surface ECG feature of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">LBBB</z:e> is a prolongation of QRS above 0.11 s in combination with a delay of the intrinsic deflection in leads V5 and V6 of more than 60 ms and no septal q waves in leads I, V5, and V6 due to the abnormal septal activation from right to left </plain></SENT>
<SENT sid="3" pm="."><plain><z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">LBBB</z:e> may induce abnormalities in left ventricular performance due to abnormal asynchronous contraction patterns which can be compensated by biventricular pacing (resynchronization therapy) </plain></SENT>
<SENT sid="4" pm="."><plain>Asynchronous electrical activation of the ventricles causes regional differences in workload which may lead to asymmetric <z:mpath ids='MPATH_159'>hypertrophy</z:mpath> and left <z:hpo ids='HP_0002119'>ventricular dilatation</z:hpo>, especially due to increased wall mass in late-activated regions, which may aggravate preexisting left ventricular pumping performance or even induce it </plain></SENT>
<SENT sid="5" pm="."><plain>Of special interest are patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">LBBB</z:e> and <z:mpath ids='MPATH_458'>normal</z:mpath> left ventricular dimensions and <z:mpath ids='MPATH_458'>normal</z:mpath> ejection fraction at rest but who may present with an abnormal increase in pulmonary artery pressure during exercise, production of <z:chebi fb="4" ids="24996">lactate</z:chebi> during high-rate pacing, signs of <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> on myocardial scintigrams (but no coronary artery narrowing), and abnormal ultrastructural findings on myocardial biopsy </plain></SENT>
<SENT sid="6" pm="."><plain>For this entity, the term latent <z:hpo ids='HP_0001638'>cardiomyopathy</z:hpo> had been suggested previously </plain></SENT>
</text></document>